Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$696,221,195
+$230,743,074 QoQ
Shares Held
580,460
+14.7% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#114
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $3,273,366,479 across 12 Drug Manufacturers - General names. LLY ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,068,333 | $1,033,234,532 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
580,460 | $696,221,195 | |
| 3 | ABBV |
AbbVie Inc.
|
1,707,786 | $429,747,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,373,431 | $304,985,883 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,033,130 | $256,865,644 | |
| 6 | AZN |
Astrazeneca PLC
|
1,328,471 | $251,904,671 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,064,284 | $118,944,044 | |
| 8 | PFE |
Pfizer Inc
|
3,938,865 | $94,847,869 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $696,221,195 | 580,460 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $465,478,121 | 506,081 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $528,004,303 | 491,313 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $199,370,374 | 261,298 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $174,515,719 | 223,873 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $208,487,764 | 252,434 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $211,899,332 | 274,481 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $238,232,809 | 268,904 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $252,737,732 | 279,151 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $219,189,452 | 281,749 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $171,964,897 | 295,006 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $182,473,266 | 339,719 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $151,796,632 | 323,674 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $92,782,811 | 270,173 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $97,779,520 | 267,274 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $83,717,901 | 258,908 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $79,121,846 | 244,030 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $50,423,456 | 176,078 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $56,391,694 | 204,155 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $55,799,499 | 241,504 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $60,828,997 | 265,027 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $54,199,097 | 290,114 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $47,526,265 | 281,487 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $39,891,241 | 269,499 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $39,737,142 | 242,034 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $19,802,141 | 142,749 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||